These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 36874700)

  • 1. Reactivation of Herpes Zoster After Recombinant Vaccine (Shingrix): A Case Report.
    Altukhaim F; Mutlaq M; Alghamdi M; Hakami S
    Cureus; 2023 Jan; 15(1):e34431. PubMed ID: 36874700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dermatomal rash after Shingrix vaccination: cause or coincidence?
    Mittal N; Dhir N; Mittal N
    Proc (Bayl Univ Med Cent); 2022; 35(5):686-687. PubMed ID: 35991721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shingrix for Herpes Zoster: A Review.
    Shah RA; Limmer AL; Nwannunu CE; Patel RR; Mui UN; Tyring SK
    Skin Therapy Lett; 2019 Jul; 24(4):5-7. PubMed ID: 31339679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Analysis of Spontaneously Reported Data of Vesicular and Bullous Cutaneous Eruptions Occurring Following Vaccination with the Adjuvanted Recombinant Zoster Vaccine.
    Pirrotta P; Tavares-Da-Silva F; Co M; Lecrenier N; Hervé C; Stegmann JU
    Drug Saf; 2021 Dec; 44(12):1341-1353. PubMed ID: 34622421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant Zoster Vaccine (Shingrix) to Prevent Herpes Zoster.
    Sly JR; Harris AL
    Nurs Womens Health; 2018 Oct; 22(5):417-422. PubMed ID: 30145235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pediatric vaccine-strain herpes zoster: a case series.
    Dreyer S; Hemarajata P; Hogeling M; Henderson GP
    Pediatr Dermatol; 2017 Nov; 34(6):665-667. PubMed ID: 28944968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Features of Varicella-Zoster Virus Infection.
    Kennedy PGE; Gershon AA
    Viruses; 2018 Nov; 10(11):. PubMed ID: 30400213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genital Herpes Zoster as Possible Indicator of HIV Infection.
    Ljubojević Hadžavdić S; Kovačević M; Skerlev M; Zekan Š
    Acta Dermatovenerol Croat; 2018 Dec; 26(4):337-338. PubMed ID: 30665486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Herpes zoster vaccination.
    Kim KH
    Korean J Pain; 2013 Jul; 26(3):242-8. PubMed ID: 23861997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Live zoster vaccination in an immunocompromised patient leading to death secondary to disseminated varicella zoster virus infection.
    Alexander KE; Tong PL; Macartney K; Beresford R; Sheppeard V; Gupta M
    Vaccine; 2018 Jun; 36(27):3890-3893. PubMed ID: 29807711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Herpes zoster ophthalmicus natural history, risk factors, clinical presentation, and morbidity.
    Liesegang TJ
    Ophthalmology; 2008 Feb; 115(2 Suppl):S3-12. PubMed ID: 18243930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute retinal necrosis following recombinant subunit varicella-zoster virus vaccine.
    Chen RI; Deaner JD; Srivastava SK; Lowder CY
    Am J Ophthalmol Case Rep; 2020 Dec; 20():100962. PubMed ID: 33163688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of herpes zoster (shingles) and postherpetic neuralgia.
    Stankus SJ; Dlugopolski M; Packer D
    Am Fam Physician; 2000 Apr; 61(8):2437-44, 2447-8. PubMed ID: 10794584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Herpes zoster and meningitis in an immunocompetent child: a case report.
    Yasuda R; Minami K; Ogawa A; Okada H; Terakawa R; Koike Y; Ogura S; Takeuchi K; Higuchi T
    J Med Case Rep; 2019 Jun; 13(1):182. PubMed ID: 31200772
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Patil A; Goldust M; Wollina U
    Viruses; 2022 Jan; 14(2):. PubMed ID: 35215786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel vaccine (Zostavax) to prevent herpes zoster and postherpetic neuralgia.
    Holcomb K; Weinberg JM
    J Drugs Dermatol; 2006 Oct; 5(9):863-6. PubMed ID: 17039651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe Herpes Zoster Following Varicella Vaccination in Immunocompetent Young Children.
    Moodley A; Swanson J; Grose C; Bonthius DJ
    J Child Neurol; 2019 Mar; 34(4):184-188. PubMed ID: 30628536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Herpes Zoster and Immunogenicity and Safety of Zoster Vaccines in Transplant Patients: A Narrative Review of the Literature.
    Wang L; Verschuuren EAM; van Leer-Buter CC; Bakker SJL; de Joode AAE; Westra J; Bos NA
    Front Immunol; 2018; 9():1632. PubMed ID: 30079064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel vaccine (Zostavax) to prevent herpes zoster.
    Holcomb K; Weinberg JM
    G Ital Dermatol Venereol; 2008 Apr; 143(2):119-23. PubMed ID: 18833038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Reactivation of herpes zoster infection by varicella-zoster virus].
    Cvjetković D; Jovanović J; Hrnjaković-Cvjetković I; Brkić S; Bogdanović M
    Med Pregl; 1999; 52(3-5):125-8. PubMed ID: 10518396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.